A detailed history of Crestline Management, LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Crestline Management, LP holds 117,681 shares of DYN stock, worth $2.82 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
117,681
Previous 92,390 27.37%
Holding current value
$2.82 Million
Previous $3.26 Million 29.66%
% of portfolio
0.22%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$31.94 - $47.04 $807,794 - $1.19 Million
25,291 Added 27.37%
117,681 $4.23 Million
Q2 2024

Aug 13, 2024

BUY
$23.65 - $35.63 $411,273 - $619,605
17,390 Added 23.19%
92,390 $3.26 Million
Q1 2024

May 14, 2024

BUY
$13.06 - $29.18 $979,500 - $2.19 Million
75,000 New
75,000 $2.13 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Crestline Management, LP Portfolio

Follow Crestline Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Crestline Management, LP with notifications on news.